• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

E-prescribing Reduces Medication Errors


E-prescribing can reduce errors in community-based practices, according to a study published in Journal of General Internal Medicine.

Journal of General Internal Medicine

E-prescribing can reduce errors in community-based practices, according to a study published in the .

When e-prescribing was used instead of traditional prescribing in community-based practices, errors were significantly reduced according to results of the study.

Researchers at Weill Medical College of Cornell University sought to investigate the effectiveness of e-prescribing by analyzing the number and severity of prescribing errors in 12 community-based medical practices in the Hudson Valley region of New York.

A comparison was made between a group of 15 doctors who utilized e-prescribing and 15 who continued to use the old method between September 2005 and June 2007. The e-prescribers used a commercial, stand-alone system with clinical decision support including dose recommendations and checks for drug-allergy interactions, drug-to-drug interactions and duplicate therapies.

The results indicated that the error rates for e-prescribing adopters decreased “nearly sevenfold one year after adoption,” while the non-adopters’ error rates remained high.

Additionally, illegibility errors were very high at baseline and were completely eliminated by e-prescribing.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice